S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Log in

Outset Medical Stock Forecast, Price & News

-0.25 (-0.51 %)
(As of 01/15/2021 12:00 AM ET)
Today's Range
Now: $49.03
50-Day Range
MA: $53.20
52-Week Range
Now: $49.03
Volume248,134 shs
Average Volume318,293 shs
Market Capitalization$2.09 billion
P/E RatioN/A
Dividend YieldN/A
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It offers Tablo, a dialysis machine that enables dialysis care in acute and chronic settings. The Tablo comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.


Overall MarketRank

0.58 out of 5 stars

Analyst Opinion: 2.3Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Electromedical equipment
Phone669 231 8200



Sales & Book Value

Annual SalesN/A



Market Cap$2.09 billion
Next Earnings Date2/10/2021 (Estimated)
OptionableNot Optionable
-0.25 (-0.51 %)
(As of 01/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive OM News and Ratings via Email

Sign-up to receive the latest news and ratings for OM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Outset Medical (NASDAQ:OM) Frequently Asked Questions

Is Outset Medical a buy right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Outset Medical in the last twelve months. There are currently 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Outset Medical stock.
View analyst ratings for Outset Medical
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Outset Medical?

Wall Street analysts have given Outset Medical a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Outset Medical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Outset Medical's next earnings date?

Outset Medical is scheduled to release its next quarterly earnings announcement on Wednesday, February 10th 2021.
View our earnings forecast for Outset Medical

How were Outset Medical's earnings last quarter?

Outset Medical, Inc. (NASDAQ:OM) posted its quarterly earnings data on Wednesday, November, 11th. The company reported ($3.44) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($3.69) by $0.25. The firm had revenue of $13.76 million for the quarter, compared to analyst estimates of $11.72 million.
View Outset Medical's earnings history

What price target have analysts set for OM?

7 equities research analysts have issued 1-year price targets for Outset Medical's stock. Their forecasts range from $52.00 to $60.00. On average, they anticipate Outset Medical's stock price to reach $55.00 in the next year. This suggests a possible upside of 12.2% from the stock's current price.
View analysts' price targets for Outset Medical
or view Wall Street analyst' top-rated stocks.

Who are some of Outset Medical's key competitors?

Who are Outset Medical's key executives?

Outset Medical's management team includes the following people:
  • Ms. Leslie L. Trigg, Pres, CEO & Director (Age 50, Pay $690.09k)
  • Ms. Rebecca Chambers, Chief Financial Officer (Age 44, Pay $485.79k)
  • Mr. Martin Vazquez, Chief Operating Officer (Age 52, Pay $591.49k)
  • Mr. John L. Brottem, Gen. Counsel (Age 48)
  • Ms. Stacey Porter, Vice Pres of People Operations
  • Dr. Michael Aragon M.D., Chief Medical Officer
  • Ms. Tonya Saffer, Head of Gov. Affairs & Market Access
  • Mr. Steve Williamson, Chief Commercial Officer
  • Phillip Oettinger, Sec.

When did Outset Medical IPO?

(OM) raised $175 million in an IPO on Tuesday, September 15th 2020. The company issued 7,600,000 shares at $22.00-$24.00 per share. BofA Securities, Morgan Stanley and Goldman Sachs served as the underwriters for the IPO and SVB Leerink and Stifel were co-managers.

What is Outset Medical's stock symbol?

Outset Medical trades on the NASDAQ under the ticker symbol "OM."

When does Outset Medical's lock-up period expire?

Outset Medical's lock-up period expires on Monday, March 15th. Outset Medical had issued 8,951,111 shares in its IPO on September 15th. The total size of the offering was $241,679,997 based on an initial share price of $27.00. After the end of Outset Medical's lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted.

How do I buy shares of Outset Medical?

Shares of OM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Outset Medical's stock price today?

One share of OM stock can currently be purchased for approximately $49.03.

How big of a company is Outset Medical?

Outset Medical has a market capitalization of $2.09 billion. Outset Medical employs 284 workers across the globe.

What is Outset Medical's official website?

The official website for Outset Medical is outsetmedical.com.

How can I contact Outset Medical?

Outset Medical's mailing address is 3052 ORCHARD DRIVE, SAN JOSE CA, 95134. The company can be reached via phone at 669 231 8200 or via email at [email protected]

This page was last updated on 1/16/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.